YANG MICHAEL J. 4
4 · ACADIA PHARMACEUTICALS INC · Filed Jan 8, 2021
Insider Transaction Report
Form 4
YANG MICHAEL J.
EVP AND CCO
Transactions
- Sale
Common Stock
2021-01-06$53.34/sh−1,120$59,741→ 8,059 total - Exercise/Conversion
Restricted Stock Units
2021-01-06−2,722→ 8,167 total→ Common Stock (2,722 underlying) - Exercise/Conversion
Common Stock
2021-01-06+2,722→ 9,179 total
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The sales reported in this Form 4 were made to cover the tax obligation that occurred upon the vesting of restricted stock units.
- [F3]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F4]The restricted stock units vest in four equal annual installments beginning January 6, 2021.